Intravenous formulations of Coenzyme Q10 (CoQ10) and methods of use thereof

Details for Australian Patent Application No. 2011224207 (hide)

Owner Berg Pharma LLC

Inventors Narain, Niven Rajin; McCook, John Patrick

Agent Spruson & Ferguson

Pub. Number AU-A-2011224207

PCT Pub. Number WO2011/112900

Priority 61/385,107 21.09.10 US; 61/313,632 12.03.10 US

Filing date 11 March 2011

Wipo publication date 15 September 2011

International Classifications

A61K 9/127 Medicinal preparations characterised by special physical form - Liposomes

A61K 9/107 Medicinal preparations characterised by special physical form - Emulsions

A61K 31/122 - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 47/30 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61P 35/00 Antineoplastic agents

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/112900 Priority application(s): WO2011/112900

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224220-Maternal sialic acid supplementation

2011224203-Hydrated crystalline forms of N- [3-fluoro-4-({6-(methyloxy)-7-[(3morpholin-4-ylpropyl)oxy]- quinolin-4-yl}oxy)phenyl] -N'-(4fluorophenyl)cyclopropane-1,1-dicarboxamide